Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of the PTPN13 expression and its clinical implication in breast cancer.

Neoplasma - 1 Apr 2023

Li Jing-Ping, Zhang Xiang-Mei, Liu Bei-Chen, Ren Shu-Guang, Zhao Xiao-Han, Liu Yun-Jiang

Abstract excerpt

Protein tyrosine phosphatases non-receptor 13 (PTPN13) could be a potential biomarker in breast cancer (BRCA), but its genetic variation and biological significance in BRCA remain undefined. Hereon, we comprehensively investigated the clinical implication of PTPN13 expression/gene mutation in BRCA. In our study, a total of 14 cases of triple-negative breast cancers (TNBC) treated with neoadjuvant therapy were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mitogen-Activated Protein Kinases
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Signal Transduction

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 36812232
DOI: 10.4149/neo_2023_221117N1110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of the PTPN13 expression and its clinical implication in breast cancer.PMID 36812232Read ↗

Bioinformatics analysis of prognostic value of TRIM13 gene in breast cancerSemantic proximity Read ↗

Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.Semantic proximity Read ↗

Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancersSemantic proximity Read ↗

Detection of aberrantly methylated tumor suppressor genes in breast cancer patients as a potential diagnostic biomarkerSemantic proximity Read ↗

The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancersSemantic proximity Read ↗

ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple‐negative breast cancerSemantic proximity Read ↗

TP53 and KMT2D mutations associated with worse prognosis in peripheral T-cell lymphomas.Semantic proximity Read ↗

Protein and transcript expression levels of TRIP13 signify worse prognosis in endometrioid carcinomaSemantic proximity Read ↗

An integrative prognostic and immune analysis of PTPRD in cancerSemantic proximity Read ↗

Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling.Semantic proximity Read ↗

The expression patterns and the prognostic roles of PTPN family members in digestive tract cancersSemantic proximity Read ↗

Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic markerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.